Biography:
Ming-Chung Jiang: CEO of Targetrust Biotech. Ltd. He has obtained a PHD in Biochemistry from the College of Medicine, National Taiwan University. He has Patents Granted: USA, China,Taiwan, Japan, Canada, Indonesia, and India. Pending: EPC
Honors:
(1) Gold Award, Taipei International Invention and competition,
(2) 2014. Silver Award, the National Invention Award, Taiwan ROC, 2016.
(3) SBIR Program Grant support, Ministry of Economic Affairs, Taiwan, 2016.
(4) TTA Prototyping Program Grant support, Ministry of Science and Technology, Taiwan, 2019.
(5) Innovation Awards, 2019 TechConnect World Innovation Conference, Boston USA.
Title : Reagent for Monitoring Cancer Therapy Resistance in Real-time (Tumor Signal-Liquid Biopsy)